Skip to main content

Table 1 Demographic characteristics, comorbidities, and their association with pulmonary pathological ultrasonographic findings and static compliance

From: Detection of residual pulmonary alterations with lung ultrasound and effects on postoperative pulmonary complications for patients with asymptomatic SARS-CoV-2 infection undergoing surgeries

 

Total patients

n = 103

Pleural thickening,

n = 29

(total n = 103)

p-value

B-lines ≥ 3,

n = 25

(total n = 103)

p-value

Compliance <50,

n = 35

(total n = 69)

p-value

Age

<50

23 (22.3)

1 (3.4)

0.005

3 (12)

0.33

6 (17.1)

0.93

50-69

43 (41.7)

12 (41.4)

 

11 (44)

 

18 (51.4)

 

≥70

37 (35.9)

16 (55.2)

 

11 (44)

 

11 (31.4)

 

Sex

Woman

45 (43.7)

8 (27.6)

0.04

8 (32)

0.33

20 (57.1)

0.18

Man

58 (56.3)

21 (72.4)

 

17 (68)

 

15 (42.9)

 

ASA

I

7 (6.8)

0 (0)

0.12

0 (0)

0.08

2 (5.7)

0.48

II

55 (53.4)

13 (44.8)

 

10 (40)

 

21 (60)

 

III

38 (36.9)

15 (51.7)

 

14 (56)

 

10 (28.6)

 

IV

3 (2.9)

1 (3.4)

 

1 (4)

 

2 (5.7)

 

Cardiopathy

27 (26.2)

11 (37.9)

0.23

10 (40)

0.18

12 (34.3)

0.43

Vascular disease

14 (13.6)

5 (17.2)

0.49

3 (12)

0.79

7 (20)

0.08

Renal disease

14 (13.6)

4 (13.8)

0.97

3 (12)

0.79

2 (5.7)

0.57

Hypertension

61 (59.2)

20 (69)

0.21

15 (60)

0.93

21 (60)

0.68

Diabetes mellitus

32 (31.1)

10 (34.4)

0.89

8 (32)

0.90

8 (22.9)

0.72

  1. Data are expressed as number (percentage